Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Change in Intangibles (2019 - 2024)

Historic Change in Intangibles for 10x Genomics (TXG) over the last 4 years, with Q2 2024 value amounting to $1.0 million.

  • 10x Genomics' Change in Intangibles changed N/A to $1.0 million in Q2 2024 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 834.24% up from last year.
  • According to the latest figures from Q2 2024, 10x Genomics' Change in Intangibles is $1.0 million.
  • In the past 5 years, 10x Genomics' Change in Intangibles ranged from a high of $1.0 million in Q2 2024 and a low of $200000.0 during Q3 2023
  • For the 3-year period, 10x Genomics' Change in Intangibles averaged around $712500.0, with its median value being $825000.0 (2020).
  • Data for 10x Genomics' Change in Intangibles shows a peak YoY increase of 360800.0% (in 2020) and a maximum YoY decrease of 360800.0% (in 2020) over the last 5 years.
  • Quarter analysis of 3 years shows 10x Genomics' Change in Intangibles stood at $927000.0 in 2020, then crashed by 78.43% to $200000.0 in 2023, then surged by 400.0% to $1.0 million in 2024.
  • Its last three reported values are $1.0 million in Q2 2024, $200000.0 for Q3 2023, and $723000.0 during Q1 2023.